Related references
Note: Only part of the references are listed.INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects
A. J. P. Smith et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
M. J. Arranz et al.
MOLECULAR PSYCHIATRY (2007)
The common genetic variant upstream of INSIG2 gene is not associated with obesity in Indian population
J. Kumar et al.
CLINICAL GENETICS (2007)
-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment
Seunghyong Ryu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts
Helen N. Lyon et al.
PLOS GENETICS (2007)
Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
Sangwon F. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database
David P. J. Osborn et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Is rs7566605, a SNP near INSIG2, associated with body mass in a randomized clinical trial of antipsychotics in schizophrenia?
T. Skelly et al.
MOLECULAR PSYCHIATRY (2007)
Lack of association between rs7566605 and obesity in a Chinese population
Yan Feng et al.
HUMAN GENETICS (2007)
Susceptibility genes for the side effect of antipsychotics on body weight and obesity
Yvon C. Chagnon
CURRENT DRUG TARGETS (2006)
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines:: Marked differences between various antipsychotic drugs
Johan Ferno et al.
BMC NEUROSCIENCE (2006)
Association of initial antipsychotic response to clozapine and long-term weight gain
Ya Mei Bai et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Prevalence of the metabolic syndrome among patients receiving clozapine
J. Steven Lamberti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A common genetic variant is associated with adult and childhood obesity
A Herbert et al.
SCIENCE (2006)
Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells
MB Raeder et al.
NEUROSCIENCE LETTERS (2006)
Genetics of antipsychotic treatment emergent weight gain in schizophrenia
Daniel J. Mueller et al.
PHARMACOGENOMICS (2006)
Clozapine-induced weight gain:: a study in monozygotic twins and same-sex sib pairs
FM Theisen et al.
PSYCHIATRIC GENETICS (2005)
Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels
AC Cervino et al.
GENOMICS (2005)
Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
J Ferno et al.
PHARMACOGENOMICS JOURNAL (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other
DR Nyholt
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Risperidone response and 5-HT6 receptor gene variance:: genetic association analysis with adjustment for nongenetic confounders
HY Lane et al.
SCHIZOPHRENIA RESEARCH (2004)
Lack of association between the-759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals
FM Theisen et al.
PSYCHIATRIC GENETICS (2004)
The effects of antipsychotic therapy on serum lipids: a comprehensive review
JM Meyer et al.
SCHIZOPHRENIA RESEARCH (2004)
Physical health monitoring of patients with schizophrenia
SR Marder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts
D Eberlé et al.
DIABETES (2004)
Cholesterol metabolism in the central nervous system during early development and in the mature animal
JM Dietschy et al.
JOURNAL OF LIPID RESEARCH (2004)
Mechanisms of regulation of gene expression by fatty acids
MT Nakamura et al.
LIPIDS (2004)
Polymorphism of the promoter region of the serotonin 5-HT2C receptor gene and clozapine-induced weight gain
GP Reynolds et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for fatty acid synthesis
D Yabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
JP Lindenmayer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER
T Yang et al.
CELL (2002)
Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism
GP Reynolds et al.
LANCET (2002)
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
JD Horton et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication
FM Theisen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2001)
Regulation of gene expression by SREBP and SCAP
PA Edwards et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
